Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 25

The DOI matches its Crossref record.

Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis

Ooi, Mian L., Richter, Katharina, Bennett, Catherine, Macias-Valle, Luis, Vreugde, Sarah, Psaltis, Alkis J., Wormald, Peter-John · 2018 · Frontiers in Microbiology

Abstract

BACKGROUND: The management of recalcitrant chronic rhinosinusitis (CRS) is challenged by difficult-to- treat polymicrobial biofilms and multidrug resistant bacteria. This has led to the search for broad-spectrum non-antibiotic antimicrobial therapies. Colloidal silver (CS) has significant antibiofilm activity in vitro and in vivo against S. aureus, MRSA and P. aeruginosa. However, due to the lack of scientific efficacy, it is only currently used as an alternative medicine. This is the first study looking at the safety and efficacy of colloidal silver in recalcitrant CRS. METHODS: Patients were included when they had previously undergone endoscopic sinus surgery and presented with signs and symptoms of sinus infection with positive bacterial cultures. 22 patients completed the study. Patients were allocated to 10-14 days of culture- directed oral antibiotics with twice daily saline rinses (n=11) or 10 days of twice daily 0.015mg/mL colloidal silver rinses (n=11). Safety observations included pre- and post- treatment serum silver levels, University of Pennsylvania Smell Identification Test (UPSIT) and adverse event (AE) reporting. Efficacy was assessed comparing microbiology results, Lund Kennedy Scores (LKS) and symptom scores using Visual Analogue Scale (VAS) and Sino-Nasal Outcome Test (SNOT-22). RESULTS: CS demonstrated good safety profile with no major adverse events, no changes in UPSIT and transient serum silver level changes in 4 patients. CS patients had 1/11 (9.09%) negative cultures, compared to 2/11 (18.18%) in the control group upon completion of the study. Whilst not statistically significant, both groups showed similar improvement in symptoms and endoscopic scores. CONCLUSION: This study concludes that twice daily CS (0.015mg/mL) sinonasal rinses for 10 days is safe but not superior to culture-directed oral antibiotics. Further studies including more patients and looking at longer treatment or improving the tonicity of the solution for better tolerability should be explored.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2018.00720

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 35

  1. 1996, Silver in Drinking Water: Background Document for the Development of WHO Guidelines for Drinking Water Quality
  2. Alandejani, 2009, Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms, Otolaryngol. Head Neck Surg., 141, 114, 10.1016/j.otohns.2009.01.005 · DOI · Paper page
  3. Bhol, 2005, Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis, Br. J. Dermatol., 152, 1235, 10.1111/j.1365-2133.2005.06575.x · DOI
  4. Chappell, 1954, Effect of silver ions on mitochondrial adenosine triphosphatase, Nature, 174, 930, 10.1038/174930b0 · doi:10.1038/174930b0
  5. Chiu, 2008, Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient, Am. J. Rhinol., 22, 34, 10.2500/ajr.2008.22.3122 · DOI · Paper page
  6. Dutsch-Wicherek, 2006, The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration, BMC Immunol., 7, 4, 10.1186/1471-2172-7-4 · doi:10.1186/1471-2172-7-4
  7. Eisenberg, 2008, [Increased expression and activity of MMP-9 in chronic rhinosinusitis with nasal polyposis], Acta Otorrinolaringol. Esp., 59, 444, 10.1016/S0001-6519(08)75116-1 · doi:10.1016/s0001-6519(08)75116-1
  8. Foreman, 2011, Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis?, Laryngoscope, 121, 1085, 10.1002/lary.21438 · DOI
  9. Fung, 1996, Silver products for medical indications: risk-benefit assessment, J. Toxicol. Clin. Toxicol., 34, 119, 10.3109/15563659609020246 · DOI · Paper page
  10. Goggin, 2014, Colloidal silver: a novel treatment for Staphylococcus aureus biofilms?, Int. Forum Allergy Rhinol., 4, 171, 10.1002/alr.21259 · DOI
  11. Jardeleza, 2011, The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis, Int. Forum Allergy Rhinol., 1, 438, 10.1002/alr.20083 · DOI
  12. Jervis-Bardy, 2012, A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis, Laryngoscope, 122, 2148, 10.1002/lary.23486 · DOI
  13. Jervis-Bardy, 2012, Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery, Int. Forum Allergy Rhinol., 2, 111, 10.1002/alr.20106 · DOI
  14. Kennedy, 2013, Sino-nasal outcome test (SNOT-22): a predictor of post-surgical improvement in patients with chronic sinusitis, Ann. Allergy Asthma Immunol., 111, 246, 10.1016/j.anai.2013.06.033 · DOI · Paper page
  15. Lansdown, 2006, Silver in health care: antimicrobial effects and safety in use, Curr. Probl. Dermatol., 33, 17, 10.1159/000093928 · DOI · Paper page
  16. Le, 2008, The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis, Am. J. Rhinol., 22, 560, 10.2500/ajr.2008.22.3232 · DOI
  17. Lund, 1995, Quantification for staging sinusitis. The Staging and Therapy Group, Ann. Otol. Rhinol. Laryngol. Suppl., 167, 17, 10.1177/000348949510410s02 · DOI · Paper page
  18. Modak, 1973, Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa, Biochem. Pharmacol, 22, 2391, 10.1016/0006-2952(73)90341-9 · DOI · Paper page
  19. Paramasivan, 2014, Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model, Int. Forum Allergy Rhinol., 4, 187, 10.1002/alr.21264 · DOI
  20. Rajiv, 2015, Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model, Int. Forum Allergy Rhinol., 5, 283, 10.1002/alr.21459 · DOI · Paper page
  21. Richter, Taking the silver bullet colloidal silver particles for the topical treatment of biofilm-related infections, ACS Appl. Mater. Interfaces, 9, 21631, 10.1021/acsami.7b03672 · DOI
  22. Richter, 2016, Mind “De GaPP”: in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms, Int. Forum Allergy Rhinol., 6, 737, 10.1002/alr.21735 · DOI
  23. Richter, A topical hydrogel with deferiprone and gallium-protoporphyrin targets bacterial iron metabolism and has antibiofilm activity, Antimicrob. Agents Chemother., 61, e00481, 10.1128/AAC.00481-17 · DOI
  24. Richter, Innovative approaches to treat Staphylococcus aureus biofilm-related infections, Essays Biochem., 61, 61, 10.1042/EBC20160056 · DOI
  25. Rosenkranz, 1972, Silver sulfadiazine: interaction with isolated deoxyribonucleic acid, Antimicrob. Agents Chemother., 2, 373, 10.1128/AAC.2.5.373 · doi:10.1128/aac.2.5.373
  26. Sauter, 2008, Regulation of matrix metalloproteinases (MMP)-2/-9 expression in eosinophilic chronic rhinosinusitis cell culture by interleukin-5 and−13?, In Vivo, 22, 415
  27. Schreurs, 1982, Effect of silver ions on transport and retention of phosphate by Escherichia coli, J. Bacteriol., 152, 7, 10.1128/jb.152.1.7-13.1982 · DOI · Paper page
  28. Seiberling, 2013, The effect of intraoperative mupirocin irrigation on Staphylococcus aureus within the maxillary sinus, Int. Forum Allergy Rhinol., 3, 94, 10.1002/alr.21076 · DOI
  29. Semeykina, 1990, Submicromolar Ag+ increases passive Na+ permeability and inhibits the respiration-supported formation of Na+ gradient in Bacillus FTU vesicles, FEBS Lett., 269, 69, 10.1016/0014-5793(90)81120-D · doi:10.1016/0014-5793(90)81120-d
  30. Solares, 2006, Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations, Am. J. Otolaryngol., 27, 161, 10.1016/j.amjoto.2005.09.006 · DOI
  31. Tomi, 2004, A silver man, Lancet, 363, 532, 10.1016/S0140-6736(04)15540-2 · doi:10.1016/s0140-6736(04)15540-2
  32. Uren, 2008, Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis, Laryngoscope, 118, 1677, 10.1097/MLG.0b013e31817aec47 · doi:10.1097/mlg.0b013e31817aec47
  33. Walker, 2000, Sinus symptom scores: what is the range in healthy individuals?, Clin. Otolaryngol. Allied Sci., 25, 482, 10.1046/j.1365-2273.2000.00349.x · doi:10.1046/j.1365-2273.2000.00349.x
  34. Wicherek, 2007, Analysis of metallothionein, RCAS1 immunoreactivity regarding immune cell concentration in the endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture, Gynecol. Obstet. Invest., 65, 52, 10.1159/000107649 · doi:10.1159/000107649
  35. Wright, 2002, Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing, Wound Repair Regen., 10, 141, 10.1046/j.1524-475X.2002.10308.x · DOI · Paper page

Cited by

Metadata

Authors
Ooi, M. L., Richter, K., Bennett, C., Macias-Valle, L., Vreugde, S., Psaltis, A. J., & Wormald, P.-J.
Venue
Frontiers in Microbiology
Published
2018-04-11
Volume
9
ISSN
1664-302X
Cited by
25
References
0
Funders
University of Adelaide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.